Xiaohui Bian, Sabena M Conley, Alfonso Eirin, Eric A Zimmerman Zuckerman, Anastasia L Smith, Cody C Gowan, Zachary K Snow, Tambi Jarmi, Houssam Farres, Young M Erben, Albert G Hakaim, Matthew A Dietz, Abba C Zubair, Saranya P Wyles, Joy V Wolfram, Lilach O Lerman, LaTonya J Hickson
BACKGROUND: Therapeutic interventions that optimize angiogenic activities may reduce rates of end-stage kidney disease, critical limb ischemia, and lower extremity amputations in individuals with diabetic kidney disease (DKD). Infusion of autologous mesenchymal stromal cells (MSC) is a promising novel therapy to rejuvenate vascular integrity. However, DKD-related factors, including hyperglycemia and uremia, might alter MSC angiogenic repair capacity in an autologous treatment approach...
March 22, 2023: Stem Cell Research & Therapy